Yong Liu

Yong Liu is currently Chairman at Sinopharm Group Beijing Huahong Co., Ltd., Sinopharm Medicine Holding Shenyang Co. Ltd. since 2003, Sinopharm Holding Beijing Co., Ltd., Sinopharm Holding Anhui Co. Ltd. since 2009, Sinopharm Group Shandong Co. Ltd. since 2009,.
Sinopharm Holding Tianxingpuxin Co. Ltd., Beijing Tianxingpuxin Bio-Med Sinopharm Holding Co., Ltd., Sinopharm Medicine Holding Chongqing Co. Ltd., Sinopharm Group Hunan Co. Ltd., Sinopharm Group Guizhou Co. Ltd., Sinopharm Group Yunnan Co. Ltd., Sinopharm Holding Beijing Kangchen Bio-medicine Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd. since 2021 as President, General Manager & Director (title start 2025), and Director at Sinopharm Holding Guoda Drugstores Co., Ltd., Sinopharm Industrial Investment Co., Ltd. since 2018, and Sinopharm Holding GuoDa Drug Store Co., Ltd. Former roles include Chairman at China National Pharmaceutical Group Co., Ltd. in 2010, Sinopharm Holding Henan Co., Ltd., Sinopharm Holding Jilin Co., Ltd. from 2010 to 2011, Beijing Konruns Pharmaceutical Co., Ltd., China National Accord Medicines Corp.
Ltd. from 2017 to 2022, China National Medicines Co., Ltd. from 2016 to 2017, President & Executive Director at Sinopharm Group Co., Ltd. from 2017 to 2024, and Deputy General Manager at Shanghai Guoda Pharmaceutical Chain-Store Co., Ltd. in 2003.
Education includes an MBA from Fudan University conferred in 2000 and an undergraduate degree from China Pharmaceutical University conferred in 1992.